As the gluten-free diet trend crests its mighty wave, and Celiac disease (the autoimmune syndrome that affects digestion of the grain protein) becomes a more common diagnosis, pharmaceutical companies are working hard to develop a pill as a first line of defense against symptoms of accidental ingestion — like headaches, bloating, abdominal pain, joint pain, diarrhea, and vomiting.
from @ Health and Medical News http://ift.tt/1R2oH8E
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
